# Center for Global Development

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/center-for-global-development/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 92.7 |
| Citations | 349,906 |
| City | Washington D.C. |
| Country | US |
| Description | Center for Global Development is a research organisation in Washington D.C., US. OpenAlex records 9,465 works and 349,906 citations for it. 1,157 researchers list it as their most recent affiliation. |
| Homepage | http://www.cgdev.org/ |
| OpenAlex ID | https://openalex.org/I1319597252 |
| Region | District of Columbia |
| Researchers | 1,157 |
| ROR ID | https://ror.org/0068yvd12 |
| Type | nonprofit |
| Wikidata ID | https://www.wikidata.org/wiki/Q3355598 |
| Works | 9,465 |

## University papers

- [Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial](https://scholariq.org/papers/atezolizumab-versus-docetaxel-in-patients-with-previously-treated-non-small-cell/)
- [Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial](https://scholariq.org/papers/atezolizumab-versus-docetaxel-for-patients-with-previously-treated-non-small/)
- [Simultaneously Mitigating Near-Term Climate Change and Improving Human Health and Food Security](https://scholariq.org/papers/simultaneously-mitigating-near-term-climate-change-and-improving-human-health/)
- [Improving our fundamental understanding of the role of aerosol−cloud interactions in the climate system](https://scholariq.org/papers/improving-our-fundamental-understanding-of-the-role-of-aerosol-cloud/)
- [Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial](https://scholariq.org/papers/atezolizumab-in-combination-with-carboplatin-and-nab-paclitaxel-in-advanced/)
- [Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)](https://scholariq.org/papers/differential-regulation-of-pd-l1-expression-by-immune-and-tumor-cells-in-nsclc/)

## University top topics

Showing 8 of 22.

- [Poverty, Education, and Child Welfare](https://scholariq.org/topics/poverty-education-and-child-welfare/)
- [Income, Poverty, and Inequality](https://scholariq.org/topics/income-poverty-and-inequality/)
- [Magnetic confinement fusion research](https://scholariq.org/topics/magnetic-confinement-fusion-research/)
- [Fiscal Policy and Economic Growth](https://scholariq.org/topics/fiscal-policy-and-economic-growth/)
- [Global Maternal and Child Health](https://scholariq.org/topics/global-maternal-and-child-health/)
- [Global trade and economics](https://scholariq.org/topics/global-trade-and-economics/)
- [Migration and Labor Dynamics](https://scholariq.org/topics/migration-and-labor-dynamics/)
- [Microfinance and Financial Inclusion](https://scholariq.org/topics/microfinance-and-financial-inclusion/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.